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Skin application of the nonsteroidal anti-
inflammatory drug ketoprofen downmodulates the 
antigen-presenting ability of Langerhans cells in mice
Does ketoprofen (KP), an inhibitor of prostaglandin (PG) synthe-
sis, affect Langerhans cell (LC) function? Ears of BALB⁄c mice were 
painted with picrylchloride (PCl) hapten, KP, or both. PCl altered 
the morphology of LCs and reduced their number, and simulta-
neous application of 10% KP maintained LC morphology and 
number. KP at 5% or 10% clearly decreased the PCl-augmented 
expression of MHC class II and CD86 on LCs. In tissue culture 
of freshly isolated epidermal cells, 5 mmol L–1 KP inhibited the 
culture-promoted expression of these molecules on LCs, whereas 
100 lmol L–1 indomethacin was not inhibitory. The further addi-
tion of PGE2 to the KP-containing epidermal cell culture did 
not restore the expression of these molecules. Moreover, topi-
cal application of 10% KP to the sensitizing sites suppressed the 
development of contact hypersensitivity to PCl. KP may have the 
potential to inhibit antigen-presenting ability of LCs, in a PGE2-
independent manner. Br J Dermatol 2008; 159:306–13.
Interaction between p53 codon 72 polymorphism 
and melanocortin 1 receptor variants on suntan 
response and cutaneous melanoma risk
Nan et al. assessed the association of the p53 codon 72 
polymorphism with tanning response, and its interaction with 
MC1R variants on tanning response and skin cancer risk, in a nest-
ed case–control study within the Nurses’ Health Study (219 cases 
of melanoma, 286 of squamous cell carcinoma, 300 of basal cell 
carcinoma and 874 controls) and among controls from four nested 
case–control studies. The p53 Pro allele was positively associated 
with childhood tanning response only among women with 
black⁄dark brown hair. Compared with the Arg⁄Arg genotype, odds 
ratios of childhood tanning tendency for Arg⁄Pro and Pro⁄Pro geno-
types were 1.59 (95% confidence interval, CI 0.96–2.65) and 1.56 
(95% CI 0.55–4.40), respectively. The association between MC1R 
variants and childhood tanning tendency was similar in both p53 
Arg⁄Arg genotype and Pro allele carriers. The association of the 
p53 Pro⁄Pro genotype with melanoma risk was strongest among 
women with light pigmentation, and with MC1R variants, with the 
joint risk categories having the highest overall risk. The study sug-
gests the involvement of p53 codon 72 polymorphism in the skin 
tanning response and potential interaction with skin pigmentation 
on melanoma risk. Br J Dermatol 2008; 159:314–21.
An evidence base for reconsidering current follow-
up guidelines for patients with cutaneous melanoma 
less than 0.5 mm thick at diagnosis
Despite current guidelines, there is uncertainty about the required 
duration and frequency of follow-up visits for patients with invasive 
primary cutaneous melanoma < 0.5 mm thick. Between 1992 and 
2001, 430 patients were diagnosed in the West of Scotland with 
melanoma < 0.5 mm. Five deaths were reported in this group of 
patients, but on pathological review two were thicker than 0.5 mm 
at diagnosis (1.5 mm and > 3 mm, respectively), and the remaining 
three all developed thicker second primary melanomas (2.7, 12.0 
and 19.0 mm) with a recurrence pattern and timing indicating that 
these thicker primaries were the cause of death. Fourteen further 
patients developed a second primary melanoma, but all are cur-
rently alive and disease free. The data indicate that recurrence and 
subsequent death from melanomas < 0.5 mm is a very rare event, 
and that quarterly follow up for 3 years will yield very few events. 
Br J Dermatol 2008; 159:337–41.
The changing face of dermatological practice:  
25 years’ experience
Benton et al. examined the change in outpatient workload over 
a 25-year period in the south east of Scotland. During a 1-month 
period, 2118 new and 2796 review consultations were available for 
analysis (new⁄review 1 : 1.3, female⁄male 1.3 : 1, age 0–106 years). 
Eighty-nine per cent of new referrals came from primary care and 
11% from secondary care. Fifty-seven per cent of referrals were 
for diagnosis and 38% for management advice. Benign tumours 
accounted for 33.4%, malignant tumours 11.6%, eczema 16% and 
psoriasis 7.4% of new cases. For return patients, 20% had skin can-
cer, 16.5% eczema, 13.4% psoriasis and 9% acne. The referral rate 
had risen over 25 years from 12.6 per 1000 population in 1980 to 
21 per 1000 in 2005, with secondary care referrals increasing from 
61 in November 1980 to 230 in November 2005. Attendances for 
benign and malignant skin tumours had increased sixfold since 
1980. Patients with eczema and psoriasis accounted for one third of 
clinic visits. New referrals had risen by 67%, with those from other 
hospital specialties almost quadrupling since 1980 to 11% of the 
total in 2005. Br J Dermatol 2008; 159:413–8.
Evidence of high levels of anxiety and depression in 
polymorphic light eruption and their association with 
clinical and demographic variables
Evidence of anxiety and depression was examined in patients 
with polymorphic light eruption (PLE). In a cross-sectional 
design, patients with PLE (n = 145) who had attended a hospital 
dermatology department completed validated questionnaires 
assessing for anxiety, depression, social anxiety and coping strat-
egies. Participants were aged 16–78 years (mean ± SD 44 ± 11.9), 
81% female, with a mean age at onset of PLE of 28 years. Evidence 
of high levels of anxiety and depression was found in PLE, with 
22.1% and 8.3% of patients scoring as probable cases for anxi-
ety and depression, respectively. Higher levels of anxiety were 
associated with younger age at onset of PLE (r = 0.25, P < 0.01) 
and facial involvement (t = 2.84, P < 0.01), and depression was 
also associated with facial involvement (t = 3.60, P < 0.01). 
Furthermore, higher levels of depression and anxiety were 
associated with the use of maladaptive coping strategies, and 
depression was found to be the principal predictor of quality of life. 
Br J Dermatol 2008; 159:439–44.
